Vor BiopharmaVOR -3.09%32 3-Year ROIIC % is 458.27 as of Dec. 2025. GuruFocus rates VOR with a GF Score™ of 32/100. The stock has 3 warning signs investors should review. Among 1,321 Biotechnology companies, Vor Biopharma ranks better than 90.16% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Vor Biopharma's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 458.27%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Vor Biopharma's 3-Year ROIIC % or its related term are showing as below:
VOR's 3-Year ROIIC % is ranked better than 90.16% of 1321
companies
in the Biotechnology industry
Industry Median: -4.44
vs VOR: 458.27
Vor Biopharma (NAS:VOR) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Vor Biopharma 3-Year ROIIC % Related Terms
Vor Biopharma 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Vor Biopharma's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VOR vs ODTX, ANNX, ABUS: 3-Year ROIIC % Comparison
For the Biotechnology subindustry, Vor Biopharma's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vor Biopharma 3-Year ROIIC % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Vor Biopharma's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Vor Biopharma's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Vor Biopharma (VOR) has a 3-Year ROIIC % of 458.27 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Vor Biopharma and its competitors. According to the industry distribution chart, Vor Biopharma ranks #130 out of 1321 companies in the Biotechnology industry, placing it in the top 9.8%.
Is Vor Biopharma's 3-Year ROIIC % too high?
Vor Biopharma's current 3-Year ROIIC % is 458.27. Based on the distribution chart, Vor Biopharma ranks #130 out of 1321 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Vor Biopharma has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Vor Biopharma's 3-Year ROIIC % compare to ODTX and ANNX?
According to the Biotechnology industry distribution chart, Vor Biopharma ranks #130 out of 1321 companies for 3-Year ROIIC %. This places Vor Biopharma in the top 10% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Biotechnology company?
A good 3-Year ROIIC % depends on the Biotechnology industry context. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Vor Biopharma and its competitors. Vor Biopharma's current 3-Year ROIIC % is 458.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vor Biopharma stock overvalued right now?
Vor Biopharma (VOR) has a current 3-Year ROIIC % of 458.27. The current 3-Year ROIIC % is 458.27. Vor Biopharma's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Vor Biopharma (VOR), the current 3-Year ROIIC % is 458.27 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
32GF Score
Get the complete analysis for VOR
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VOR has been successfully added to your 
